2321 High response rate and progression free survival with PEGylated recombinant human hyaluronidase added to Nab-Paclitaxel/ Gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized Phase 2 study. (September 2015) - Hingorani, S.; Harris, W.; Hendifar, A.; Bullock, A.; Wu, X.; Huang, Y.; Jiang, P.; Hoff, D. Von